All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
University of California, San Francisco Dr. Jeffrey A Bluestone Disease Team Planning A CIRM Disease Team for the Treatment and Cure of Diabetes $55,000
University of Southern California Dr. Chrysostomos L. Max Nikias Major Facilities Broad CIRM Facility at USC $26,972,500
University of California, San Francisco Dr. A. Eugene Washington Major Facilities UCSF CIRM Building $34,862,400
University of California, Santa Cruz Margaret L. Delaney Major Facilities UC Santa Cruz IBSC Facility $7,191,950
University of California, Santa Barbara Glenn E Lucas Major Facilities UC Santa Barbara Bio Sciences II $3,205,800
University of California, Merced John O. White Major Facilities Stem Cell Instrumentation Foundry $4,341,321
University of California, Los Angeles Dr. Gene D. Block Major Facilities UCLA CIRM Institute $19,854,900
University of California, Irvine Dr. Michael V Drake Major Facilities UC Irvine CIRM Institute $27,156,000
University of California, Davis Dr. Larry N. Vanderhoef Major Facilities UC Davis CIRM Institute $20,082,400
University of California, Berkeley Dr. George W. Breslauer Major Facilities UC Berkeley CIRM Center of Excellence $20,183,500
Stanford University Dr. John L. Hennessy Major Facilities Stanford SIM1 Building $43,578,000
Sanford Consortium for Regenerative Medicine Edward Holmes Major Facilities Sanford Consortium for Regenerative Medicine $42,827,439
Buck Institute for Age Research Mary McEachron Major Facilities CIRM Center of Excellence at Buck Institute for Age Research $20,500,000
University of California, Los Angeles Dr. Bennett G Novitch Basic Biology V In vitro modeling of human motor neuron disease $1,148,758
Stanford University Dr. Helen M Blau Basic Biology V Mass Cytometry to Delineate the Human Muscle Stem Cell Hierarchy and Dysfunction in Aging $1,175,357
Stanford University Dr. Marius Wernig MD, PhD Basic Biology V Mechanisms of human induced neuronal cell reprogramming $1,178,370
University of California, Irvine Dr. Peter J Donovan Basic Biology V Non-invasive live imaging of stem cell signature metabolic states $516,366
Palo Alto Veterans Institute for Research Dr. Thomas A. Rando Basic Biology V Molecular regulation of stem cell potency $966,510
University of California, Merced Dr. Kara E McCloskey Basic Biology V Directed Differentiation of Specialized Endothelial Cells $475,686
University of California, San Francisco Dr. Valerie Marie Weaver Basic Biology V Biophysical Determinants of Early Embryonic Stem Cell Fate Specification $1,186,500
California Institute of Technology Dr. David Anthony Tirrell Basic Biology V Engineered matrices for control of lineage commitment in human pancreatic stem cells $526,896
Salk Institute for Biological Studies Ronald Mark Evans Basic Biology V Metabolically-driven epigenetic changes in iPSC reprogramming $1,491,900
University of California, San Diego Dr. Dianne McKay Basic Biology V Role of intracytoplasmic pattern recognition receptors in HSC engraftment $615,639
Stanford University Dr. Gary Steinberg Basic Biology V Paracrine and synaptic mechanisms underlying neural stem cell-mediated stroke recovery $1,178,370
University of California, San Diego Christian Metallo Basic Biology V Metabolic regulation of cardiac differentiation and maturation $1,124,834
University of California, Los Angeles Dr Samantha J Butler Ph.D. Basic Biology V Assessing the mechanism by which the Bone Morphogenetic Proteins direct stem cell fate $515,730
Cedars-Sinai Medical Center Paul W Noble Basic Biology V Innate Immune Regulation of Lung Alveolar Stem Cell Renewal in Mouse and Man $617,662
Gladstone Institutes, J. David Sheng Ding PhD Basic Biology V A novel druggable mechanism to safeguard stem cell genome $1,294,495
University of California, San Francisco Dr. Mark S. Anderson Basic Biology V Generation of a functional thymus to induce immune tolerance to stem cell derivatives $1,191,000
University of California, Irvine Dr. Lisa A Flanagan Basic Biology V Molecular basis of plasma membrane characteristics reflecting stem cell fate potential $994,108
University of California, San Diego Maike Sander Basic Biology V Defining links between chromatin state and developmental competence $1,050,300
University of Southern California Dr. Denis A Evseenko Dr. Basic Biology V Promoting survival and countering hypertrophy of pluripotent stem cell (PSC)-derived chondrocytes $735,138
University of California, Los Angeles Dr. Denis A Evseenko Dr. Basic Biology V Promoting survival and countering hypertrophy of pluripotent stem cell (PSC)-derived chondrocytes $411,330
University of California, San Diego Miles F Wilkinson Basic Biology V New Regulators of Spermatogonial Stem Cells: RHOX Homeobox Transcription Factors $552,811
University of California, Los Angeles Dr. Lili Yang Basic Biology V Differentiation of Human Hematopoietic Stem Cells into iNKT Cells $614,400
University of California, San Diego Dr. Cornelis Murre Basic Biology V Epigenetic mechanisms that enforce pluripotency in embryonic stem cells $1,160,997
University of California, San Diego Dr. Wei Wang Basic Biology V Systems-level discovery of the regulatory mechanisms directing differentiation of hESC $1,161,000
University of California, San Diego Dr. Lawrence S. B. Goldstein Basic Biology V Elucidating pathways from hereditary Alzheimer mutations to pathological tau phenotypes $1,050,300
University of California, San Diego Dr. David A. Cheresh Basic Biology V CD61-driven stemness program in epithelial cancer $1,161,000
University of California, Berkeley Dr. Andrew Dillin Basic Biology V A Requirement for Protein Homeostasis in the Mediation of Stem Cell Health $1,034,100
Stanford University Xinnan Wang Basic Biology V Misregulated Mitophagy in Parkinsonian Neurodegeneration $1,174,943
University of Southern California Dr. Mark S Humayun Disease Team Therapy Development III Phase 1 Safety Assessment of CPCB-RPE1, hESC-derived RPE Cell Coated Parylene Membrane Implants, in Patients with Advanced Dry Age Related Macular Degeneration $16,339,827
University of California, Davis Dr. Peter C. Belafsky Disease Team Therapy Development III Tissue Engineered Recellularized Laryngotracheal Implants $3,181,162
University of California, Los Angeles Dr. Dennis J Slamon Disease Team Therapy Development III A Phase I dose escalation and expansion clinical trial of the novel first-in-class Polo-like Kinase 4 (PLK4) inhibitor, CFI-400945 in patients with advanced solid tumors $5,683,693
Stanford University Professor Irving L Weissman MD Disease Team Therapy Development III Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Hematologic Malignancies and Solid Tumors $6,505,568
University of California, Los Angeles Dr. Donald B. Kohn PhD Disease Team Therapy Development III Clinical Trial of Stem Cell Gene Therapy for Sickle Cell Disease $13,145,465
University of California, San Diego Thomas J Kipps Disease Team Therapy Development III Therapeutic Eradication of Cancer Stem Cells with UC-961 (Cirmtuzumab) $4,179,598
Sangamo BioSciences, Inc. Dr. Fyodor D Urnov Strategic Partnership II A Treatment For Beta-thalassemia via High-Efficiency Targeted Genome Editing of Hematopoietic Stem Cells $2,760,540
Human BioMolecular Research Institute Dr. John R Cashman Patent Assistance Fund Awards Intellectual Property for Stem Cell-Related Inventions – HBRI $50,000
University of California, San Francisco Karin Immergluck PhD Patent Assistance Fund Awards Patent Assistance Fund Proposal – UCSF $87,257
1 … 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 … 30